Skip to main navigation
Skip to search
Skip to main content
Fujita Health University Home
English
日本語
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer
S. Kamoshida
, M. Suzuki
, R. Shimomura
, Y. Sakurai
, Y. Komori
,
I. Uyama
, Y. Tsutsumi
Research output
:
Contribution to journal
›
Article
›
peer-review
29
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Immunostaining
100%
Cisplatin
100%
Gastric Cancer
100%
Chemoresistance
100%
Thymidylate Synthase
100%
High-level Expression
42%
Non-responders
42%
Pretreatment Biopsy
42%
P53 Expression
28%
P53 Protein
28%
Surgical Specimen
28%
Cisplatin-based Chemotherapy
28%
Histologic
14%
Biopsy Specimen
14%
Neoadjuvant Chemotherapy
14%
Neoadjuvant
14%
Paraffin Section
14%
Gastric Cancer Patients
14%
Antigen Retrieval
14%
Biochemistry, Genetics and Molecular Biology
P53
100%
Drug Resistance
100%
Immunostaining
100%
Cisplatin
100%
Thymidylate Synthase
100%
Information Retrieval
14%
Veterinary Science and Veterinary Medicine
Stomach Cancer
100%
P53
100%
Neuroscience
Thymidylate Synthase
100%